Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
|
|
CYNOSURE INC (CYNO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2017 |
8-K
| Quarterly results |
| 02/22/2017 |
8-K
| Form 8-K - Current report |
| 02/14/2017 |
8-K
| Form 8-K - Current report |
| 02/07/2017 |
8-K
| Form 8-K - Current report |
| 01/27/2017 |
8-K
| Form 8-K - Current report |
| 12/16/2016 |
8-K
| Form 8-K - Current report |
| 10/25/2016 |
8-K
| Form 8-K - Current report |
| 10/21/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/13/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/26/2016 |
8-K
| Form 8-K - Current report |
| 07/22/2016 |
8-K
| Form 8-K - Current report |
| 05/25/2016 |
8-K
| Form 8-K - Current report |
| 05/16/2016 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 04/26/2016 |
8-K
| Quarterly results |
| 02/09/2016 |
8-K
| Form 8-K - Current report |
| 02/05/2016 |
8-K
| Form 8-K - Current report |
| 10/27/2015 |
8-K
| Quarterly results |
| 07/28/2015 |
8-K
| Quarterly results |
| 05/18/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/05/2015 |
8-K
| Quarterly results|
Docs:
|
"Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year First-Quarter Highlights: • North America product revenue growth of 45 percent • Non-GAAP earnings of $0.15 per share; GAAP earnings break-even • Cash and investments of $126.6 million at March 31, 2015 Westford, MA - May 5, 2015 - Cynosure, Inc. , which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended March 31, 2015. “Cynosure delivered 21 percent year-over-year top-line growth in the first quarter, reflecting higher laser revenue in North America, which was up 45 percent from the same period last year,” said Michael Davin, Cynosu...",
"Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year First-Quarter Highlights: • North America product revenue growth of 45 percent • Non-GAAP earnings of $0.15 per share; GAAP earnings break-even • Cash and investments of $126.6 million at March 31, 2015 Westford, MA - May 5, 2015 - Cynosure, Inc. , which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended March 31, 2015. “Cynosure delivered 21 percent year-over-year top-line growth in the first quarter, reflecting higher laser revenue in North America, which was up 45 percent from the same period last year,” said Michael Davin, Cynosu..." |
|
| 02/10/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 11/07/2014 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Independent Auditors",
"Independent Auditors' Report, audited consolidated balance sheets of Ellman as of December 31, 2013 and 2012, the audited consolidated statements of operations, stockholders' equity and cash flows for the years ended December 31, 2013, 2012 and 2011, and the notes to consolidated financial statements",
"Consolidated balance sheets of Ellman as of June 30, 2014 (unaudited) and December 31, 2013 (audited), the unaudited consolidated statements of operations and cash flows for the six months ended June 30, 2014 and 2013, and the notes to consolidated financial statements",
"Unaudited pro forma combined balance sheet as of June 30, 2014 as if Cynosure's acquisition of substantially all of the assets of Ellman occurred on June 30, 2014, and the unaudited pro forma combined statements of operations for the six months ended June 30, 2014 and the year ended December 31, 2013 as if Cynosure's acquisition of substantially all of the assets of Ellman occurred on January 1, 2013" |
|
| 10/28/2014 |
8-K
| Quarterly results |
| 10/06/2014 |
8-K
| Other Events |
| 09/08/2014 |
8-K
| Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits |
| 07/30/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/29/2014 |
8-K
| Quarterly results |
| 06/20/2014 |
8-K
| Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits |
| 05/15/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/06/2014 |
8-K
| Quarterly results |
| 02/12/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 12/02/2013 |
8-K
| Form 8-K - Current report |
| 11/22/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 10/29/2013 |
8-K
| Form 8-K - Current report |
|
|
|